{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001130193.1:c.90C>T",
          "cDNA Change": {
            "transcript": "NM_001130193.1",
            "ref": "C",
            "alt": "T",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation in alpha-synuclein"
        },
        {
          "HGVS": "NM_001130193.1:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_001130193.1",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in alpha-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005157"
  },
  "Experiment Method": [
    {
      "Assay Method": "Metal ion binding assay (Cu²⁺ binding)",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Wild-type and mutant alpha-synuclein (A30P, A53T)",
        "Description": "Binding of Cu²⁺ to wild-type and mutant alpha-synuclein proteins was measured under physiological conditions."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130193.1:c.90C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced Cu²⁺ binding affinity",
          "Result Description": "A30P mutation showed lower binding constants (Kd) compared to wild-type protein."
        },
        {
          "Variant": "NM_001130193.1:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced Cu²⁺ binding affinity",
          "Result Description": "A53T mutation exhibited altered binding stoichiometry and lower Kd values compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were performed with wild-type and mutant proteins."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each measurement was repeated in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein was used as a positive control for binding."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Protein-free buffer was used as a negative control for binding."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare binding constants across groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cu²⁺ binding affinity within 10% of wild-type Kd values.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cu²⁺ binding affinity reduced by >20% compared to wild-type Kd values.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}